Federal prosecutors say justice caught up with Scharmaine Lawson Baker, the nurse practitioner accused of signing hundreds of medically unnecessary cancer genetic tests and billing Medicare for more than $12 million. Reported sentences put her behind bars for 87 months, with more than $1.5 million in restitution and three years of supervised release. The case is a blunt reminder that fraud still eats Medicare from the inside.
Sentenced for $12 million Medicare fraud
The story is simple and ugly. Prosecutors say Lawson Baker, who held herself out as a Medicare expert and even wrote books about medical necessity, signed a flood of genetic test orders after phone calls that lasted 30 seconds or less. The telehealth operation allegedly told her she’d be “rolling in money,” and the recording admitted at trial captured her reply: “Honey, I am not complaining.” She ordered tests that made no clinical sense — even ovarian and cervical tests for male patients — and never reviewed the results. The scheme caused over $12.1 million in false Medicare claims, and the labs got roughly $1.5 million in reimbursements.
How the scheme worked — and why it was so brazen
This was not sloppy medicine. Prosecutors presented audio, notes, and records showing she acted like a rubber stamp in exchange for kickbacks. A jury convicted her after a three-day trial last year, and now the reported sentence — 87 months behind bars — aims to match the scale of the theft. Assistant Attorney General Colin M. McDonald, U.S. Attorney David I. Courcelle, HHS‑OIG Special Agent in Charge Jason E. Meadows, and FBI Special Agent in Charge Jonathan Tapp were among the officials tied to the prosecution. Their message: Medicare fraud will get you more than a slap on the wrist.
Why the result matters — but why vigilance must continue
Good. We should applaud a strong response. The Department of Justice’s new National Fraud Enforcement Division and the Health Care Fraud Strike Force have tools to go after big, organized schemes that drain taxpayer dollars. But prosecution of one practitioner isn’t enough. The telehealth brokers, marketers, and labs who profit from volume-driven fraud need real consequences — civil suits, exclusions from federal programs, and tighter CMS oversight. Otherwise, another scheme will replace this one while officials write press releases.
One caveat: multiple outlets report the June sentencing, but a formal DOJ or USAO sentencing release or the court’s signed Judgment & Commitment should be retrieved via PACER for the final word. Still, whether the paperwork is stamped in PACER or not, the pattern of abuse is clear: a trusted medical license used to rake in cash at taxpayers’ expense. Congress and regulators should take note and act — because taxpayers tired of footing the bill for someone else’s “rolling in money” moment. If anyone still thinks telehealth can’t be gamed, they haven’t been paying attention.

